Evidence map›Paper›PMID 28120151›Full record

ArticleMolecular neurobiology2018

The Ying and Yang of Adenosine A

Reham M Atef, Azza M Agha, Abdel-Rahman A Abdel-Rhaman, Noha N Nassar

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Adenosine AMolecular neurobiology · 2022
    Article
  5. Review
  6. The Nrf2 Pathway in Ischemic Stroke: A Review.Molecules (Basel, Switzerland) · 2021
    Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Reham M AtefDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo, 11562, Egypt.
Azza M AghaDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo, 11562, Egypt.
Abdel-Rahman A Abdel-RhamanDepartment of Pharmacology and Toxicology, Brody School of Medicine, East Carolina University, Greenville, NC, USA.
Noha N NassarDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo, 11562, Egypt. noha.nassar@pharma.cu.edu.eg.
Cairo University · EGEast Carolina University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adenosine impacts cerebral ischemia reperfusion (IR) through the inhibitory A

Indexed as

AdenosineAdenosine A1 Receptor AgonistsAdenosine A2 Receptor AgonistsAnimalsBehavior, AnimalBrain-Derived Neurotrophic FactorCaspase 3Disease Models, AnimalHippocampusMaleMAP Kinase Signaling SystemMaze LearningMemoryMicrogliaMotor SkillsPhenethylamines2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosineAdenosineAdenosine A1 Receptor AgonistsAdenosine A2 Receptor AgonistsBrain-Derived Neurotrophic FactorCaspase 3PhenethylaminesReceptor, Adenosine A1Receptor, Adenosine A2AThiobarbituric Acid Reactive SubstancesTumor Necrosis Factor-alphaAdenosineGlobal cerebral ischemia reperfusion—pERK1/2Glutamate—NF-κBMicroglial reactivity

Identifiers

PMID28120151
OpenAlexW2581244306

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.